PTGS2 and triple-negative breast carcinoma: Mechanistically, OC inhibits NF-κB-dependent COX-2 transcription by blocking IκBα phosphorylation and nuclear translocation of p65, as demonstrated in triple-negative breast cancer (TNBC) models [30].